ºÝºÝߣshows by User: IMSHealthRWES / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: IMSHealthRWES / Tue, 07 Jun 2016 03:35:57 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: IMSHealthRWES Advocacy and the cancer patient viewpoint /slideshow/advocacy-and-the-cancer-patient-viewpoint/62794080 patientadvocacyfromimsrwesaccesspoint12-160607033557
An excerpt from our 12th issue of AccessPoint that explores the evolving role of patient advocacy groups in generating and using RWE]]>
An excerpt from our 12th issue of AccessPoint that explores the evolving role of patient advocacy groups in generating and using RWE]]> Tue, 07 Jun 2016 03:35:57 GMT /slideshow/advocacy-and-the-cancer-patient-viewpoint/62794080 IMSHealthRWES@slideshare.net(IMSHealthRWES) Advocacy and the cancer patient viewpoint IMSHealthRWES An excerpt from our 12th issue of AccessPoint that explores the evolving role of patient advocacy groups in generating and using RWE <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/patientadvocacyfromimsrwesaccesspoint12-160607033557-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> An excerpt from our 12th issue of AccessPoint that explores the evolving role of patient advocacy groups in generating and using RWE
Advocacy and the cancer patient viewpoint from IMSHealthRWES
]]> 935 11 https://cdn.slidesharecdn.com/ss_thumbnails/patientadvocacyfromimsrwesaccesspoint12-160607033557-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 AccessPoint Excerpt - The potential for RWE to improve care inmalignant melanoma /IMSHealthRWES/accesspoint-excerpt-the-potential-for-rwe-to-improve-care-inmalignant-melanoma melanomascandifromimsrwesaccesspoint12-160603152035
An excerpt from our 12th issue of AccessPoint - The potential for RWE to improve individualized care in cutaneous malignant melanoma]]>
An excerpt from our 12th issue of AccessPoint - The potential for RWE to improve individualized care in cutaneous malignant melanoma]]> Fri, 03 Jun 2016 15:20:34 GMT /IMSHealthRWES/accesspoint-excerpt-the-potential-for-rwe-to-improve-care-inmalignant-melanoma IMSHealthRWES@slideshare.net(IMSHealthRWES) AccessPoint Excerpt - The potential for RWE to improve care inmalignant melanoma IMSHealthRWES An excerpt from our 12th issue of AccessPoint - The potential for RWE to improve individualized care in cutaneous malignant melanoma <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/melanomascandifromimsrwesaccesspoint12-160603152035-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> An excerpt from our 12th issue of AccessPoint - The potential for RWE to improve individualized care in cutaneous malignant melanoma
AccessPoint Excerpt - The potential for RWE to improve care inmalignant melanoma from IMSHealthRWES
]]> 671 4 https://cdn.slidesharecdn.com/ss_thumbnails/melanomascandifromimsrwesaccesspoint12-160603152035-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 How patient subpopulations are changing the commercialization of oncology products /slideshow/how-patient-subpopulations-are-changing-the-commercialization-of-oncology-products/62410358 patientsubpopulationsfromimsrwesaccesspoint12-160526025935
An excerpt from the latest issue of AccessPoint, looking at how genomic profiling data is transforming our understanding of patient subpopulations - a key to targeting treatments with greater precision]]>
An excerpt from the latest issue of AccessPoint, looking at how genomic profiling data is transforming our understanding of patient subpopulations - a key to targeting treatments with greater precision]]> Thu, 26 May 2016 02:59:35 GMT /slideshow/how-patient-subpopulations-are-changing-the-commercialization-of-oncology-products/62410358 IMSHealthRWES@slideshare.net(IMSHealthRWES) How patient subpopulations are changing the commercialization of oncology products IMSHealthRWES An excerpt from the latest issue of AccessPoint, looking at how genomic profiling data is transforming our understanding of patient subpopulations - a key to targeting treatments with greater precision <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/patientsubpopulationsfromimsrwesaccesspoint12-160526025935-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> An excerpt from the latest issue of AccessPoint, looking at how genomic profiling data is transforming our understanding of patient subpopulations - a key to targeting treatments with greater precision
How patient subpopulations are changing the commercialization of oncology products from IMSHealthRWES
]]> 413 8 https://cdn.slidesharecdn.com/ss_thumbnails/patientsubpopulationsfromimsrwesaccesspoint12-160526025935-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 The Current Oncology Pipeline: Development & Launch /slideshow/the-current-oncology-pipeline-development-launch-62349110/62349110 pipelinefromimsaccesspoint12-160524152111
A compelling infographic from the latest issue of AccessPoint demonstrating what is in the oncology pipeline, both in development and launch phases. ]]>
A compelling infographic from the latest issue of AccessPoint demonstrating what is in the oncology pipeline, both in development and launch phases. ]]> Tue, 24 May 2016 15:21:10 GMT /slideshow/the-current-oncology-pipeline-development-launch-62349110/62349110 IMSHealthRWES@slideshare.net(IMSHealthRWES) The Current Oncology Pipeline: Development & Launch IMSHealthRWES A compelling infographic from the latest issue of AccessPoint demonstrating what is in the oncology pipeline, both in development and launch phases. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pipelinefromimsaccesspoint12-160524152111-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A compelling infographic from the latest issue of AccessPoint demonstrating what is in the oncology pipeline, both in development and launch phases.
The Current Oncology Pipeline: Development & Launch from IMSHealthRWES
]]> 836 6 https://cdn.slidesharecdn.com/ss_thumbnails/pipelinefromimsaccesspoint12-160524152111-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 IMS Health RWES: The Future of Real-World Insights in Cancer /slideshow/ims-health-rwes-the-future-of-realworld-insights-in-cancer/62156888 28028oncologybrochurecrx-160518191307
IMS Health RWES: The Future of Real-World Insights in Cancer]]>
IMS Health RWES: The Future of Real-World Insights in Cancer]]> Wed, 18 May 2016 19:13:07 GMT /slideshow/ims-health-rwes-the-future-of-realworld-insights-in-cancer/62156888 IMSHealthRWES@slideshare.net(IMSHealthRWES) IMS Health RWES: The Future of Real-World Insights in Cancer IMSHealthRWES IMS Health RWES: The Future of Real-World Insights in Cancer <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/28028oncologybrochurecrx-160518191307-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> IMS Health RWES: The Future of Real-World Insights in Cancer
IMS Health RWES: The Future of Real-World Insights in Cancer from IMSHealthRWES
]]> 1681 11 https://cdn.slidesharecdn.com/ss_thumbnails/28028oncologybrochurecrx-160518191307-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 IMS Health at ISPOR - Washington DC - May 2016 /slideshow/ims-health-at-ispor-washington-dc-may-2016/62152687 imshwashingtonisporinvite2016-160518171713
IMS Health program of activities at ISPOR Washington DC 2016]]>
IMS Health program of activities at ISPOR Washington DC 2016]]> Wed, 18 May 2016 17:17:13 GMT /slideshow/ims-health-at-ispor-washington-dc-may-2016/62152687 IMSHealthRWES@slideshare.net(IMSHealthRWES) IMS Health at ISPOR - Washington DC - May 2016 IMSHealthRWES IMS Health program of activities at ISPOR Washington DC 2016 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imshwashingtonisporinvite2016-160518171713-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> IMS Health program of activities at ISPOR Washington DC 2016
IMS Health at ISPOR - Washington DC - May 2016 from IMSHealthRWES
]]> 651 10 https://cdn.slidesharecdn.com/ss_thumbnails/imshwashingtonisporinvite2016-160518171713-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 IMS Health Real-World Evidence Brochure /slideshow/ims-health-realworld-evidence-brochure/61300938 imsrecruitingbrochurefinal4-160425020259
We are advancing global healthcare - come join us! ]]>
We are advancing global healthcare - come join us! ]]> Mon, 25 Apr 2016 02:02:58 GMT /slideshow/ims-health-realworld-evidence-brochure/61300938 IMSHealthRWES@slideshare.net(IMSHealthRWES) IMS Health Real-World Evidence Brochure IMSHealthRWES We are advancing global healthcare - come join us! <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imsrecruitingbrochurefinal4-160425020259-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> We are advancing global healthcare - come join us!
IMS Health Real-World Evidence Brochure from IMSHealthRWES
]]> 851 6 https://cdn.slidesharecdn.com/ss_thumbnails/imsrecruitingbrochurefinal4-160425020259-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 AccessPoint - 9th Issue - November 2014 /slideshow/accesspoint-9th-issue-november-2014/60615771 imsrweaccesspoint91114v2pages-160407151606
News, views and insights from leading international experts in RWE and HEOR]]>
News, views and insights from leading international experts in RWE and HEOR]]> Thu, 07 Apr 2016 15:16:06 GMT /slideshow/accesspoint-9th-issue-november-2014/60615771 IMSHealthRWES@slideshare.net(IMSHealthRWES) AccessPoint - 9th Issue - November 2014 IMSHealthRWES News, views and insights from leading international experts in RWE and HEOR <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imsrweaccesspoint91114v2pages-160407151606-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> News, views and insights from leading international experts in RWE and HEOR
AccessPoint - 9th Issue - November 2014 from IMSHealthRWES
]]> 477 10 https://cdn.slidesharecdn.com/ss_thumbnails/imsrweaccesspoint91114v2pages-160407151606-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 IMS Health Workshop World Orphan Drug Congress /slideshow/ims-health-workshop-world-orphan-drug-congress/59257692 imshealthworkshopwodcapril201-160308133207
Using RWE to find undiagnosed patients with rare diseases]]>
Using RWE to find undiagnosed patients with rare diseases]]> Tue, 08 Mar 2016 13:32:07 GMT /slideshow/ims-health-workshop-world-orphan-drug-congress/59257692 IMSHealthRWES@slideshare.net(IMSHealthRWES) IMS Health Workshop World Orphan Drug Congress IMSHealthRWES Using RWE to find undiagnosed patients with rare diseases <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imshealthworkshopwodcapril201-160308133207-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Using RWE to find undiagnosed patients with rare diseases
IMS Health Workshop World Orphan Drug Congress from IMSHealthRWES
]]> 1579 6 https://cdn.slidesharecdn.com/ss_thumbnails/imshealthworkshopwodcapril201-160308133207-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 How predictive analytics can help find the rare disease patient /slideshow/predictive-analytics-58625341/58625341 predictiveanalytics-160223193629
A groundbreaking, real-world approach to identifying patients to accelerate treatment.]]>
A groundbreaking, real-world approach to identifying patients to accelerate treatment.]]> Tue, 23 Feb 2016 19:36:29 GMT /slideshow/predictive-analytics-58625341/58625341 IMSHealthRWES@slideshare.net(IMSHealthRWES) How predictive analytics can help find the rare disease patient IMSHealthRWES A groundbreaking, real-world approach to identifying patients to accelerate treatment. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/predictiveanalytics-160223193629-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A groundbreaking, real-world approach to identifying patients to accelerate treatment.
How predictive analytics can help find the rare disease patient from IMSHealthRWES
]]> 2245 6 https://cdn.slidesharecdn.com/ss_thumbnails/predictiveanalytics-160223193629-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Convergence of HTA assessments in Europe /slideshow/convergence-of-hta-assessments-in-europe/57386675 convergenceofhtaassessments-160122195831
Health policy developments across Europe continue to focus on the dual ambition of controlling costs while improving access to innovative drugs.]]>
Health policy developments across Europe continue to focus on the dual ambition of controlling costs while improving access to innovative drugs.]]> Fri, 22 Jan 2016 19:58:31 GMT /slideshow/convergence-of-hta-assessments-in-europe/57386675 IMSHealthRWES@slideshare.net(IMSHealthRWES) Convergence of HTA assessments in Europe IMSHealthRWES Health policy developments across Europe continue to focus on the dual ambition of controlling costs while improving access to innovative drugs. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/convergenceofhtaassessments-160122195831-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Health policy developments across Europe continue to focus on the dual ambition of controlling costs while improving access to innovative drugs.
Convergence of HTA assessments in Europe from IMSHealthRWES
]]> 1021 5 https://cdn.slidesharecdn.com/ss_thumbnails/convergenceofhtaassessments-160122195831-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Prospective identification of drug safety signals /slideshow/prospective-identification-of-drug-safety-signals/56973230 prospectiveidentificationofdrugsafetysignals-160112194249
At a time of growing demand for more accurate and timely drug safety evidence, a landmark study supports the value of electronic medical records (EmR) for detecting new adverse reactions.]]>
At a time of growing demand for more accurate and timely drug safety evidence, a landmark study supports the value of electronic medical records (EmR) for detecting new adverse reactions.]]> Tue, 12 Jan 2016 19:42:49 GMT /slideshow/prospective-identification-of-drug-safety-signals/56973230 IMSHealthRWES@slideshare.net(IMSHealthRWES) Prospective identification of drug safety signals IMSHealthRWES At a time of growing demand for more accurate and timely drug safety evidence, a landmark study supports the value of electronic medical records (EmR) for detecting new adverse reactions. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/prospectiveidentificationofdrugsafetysignals-160112194249-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> At a time of growing demand for more accurate and timely drug safety evidence, a landmark study supports the value of electronic medical records (EmR) for detecting new adverse reactions.
Prospective identification of drug safety signals from IMSHealthRWES
]]> 513 8 https://cdn.slidesharecdn.com/ss_thumbnails/prospectiveidentificationofdrugsafetysignals-160112194249-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Facts Addressing Migraine Market Misperceptions /slideshow/migraine-market-misperceptions/56706558 migrainemarketmisperceptions-160105171626
CoLucid Pharmaceuticals and IMS Health publish White Paper to address migraine market misperceptions]]>
CoLucid Pharmaceuticals and IMS Health publish White Paper to address migraine market misperceptions]]> Tue, 05 Jan 2016 17:16:26 GMT /slideshow/migraine-market-misperceptions/56706558 IMSHealthRWES@slideshare.net(IMSHealthRWES) Facts Addressing Migraine Market Misperceptions IMSHealthRWES CoLucid Pharmaceuticals and IMS Health publish White Paper to address migraine market misperceptions <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/migrainemarketmisperceptions-160105171626-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> CoLucid Pharmaceuticals and IMS Health publish White Paper to address migraine market misperceptions
Facts Addressing Migraine Market Misperceptions from IMSHealthRWES
]]> 12511 23 https://cdn.slidesharecdn.com/ss_thumbnails/migrainemarketmisperceptions-160105171626-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Enabling clinical trial expansion /slideshow/enabling-clinical-trial-expansion/56668392 enablingclinicaltrialexpansion-160104210412
Innovative application of RWD]]>
Innovative application of RWD]]> Mon, 04 Jan 2016 21:04:12 GMT /slideshow/enabling-clinical-trial-expansion/56668392 IMSHealthRWES@slideshare.net(IMSHealthRWES) Enabling clinical trial expansion IMSHealthRWES Innovative application of RWD <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/enablingclinicaltrialexpansion-160104210412-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Innovative application of RWD
Enabling clinical trial expansion from IMSHealthRWES
]]> 431 8 https://cdn.slidesharecdn.com/ss_thumbnails/enablingclinicaltrialexpansion-160104210412-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 EMR as a highly powerful European RWD source /IMSHealthRWES/emr-as-a-highly-powerful-european-rwd-source emrasahighlypowerfuleuropeanrwdsource-151222195711
A novel approach for supporting a clinical trial in Europe using EMR data ]]>
A novel approach for supporting a clinical trial in Europe using EMR data ]]> Tue, 22 Dec 2015 19:57:11 GMT /IMSHealthRWES/emr-as-a-highly-powerful-european-rwd-source IMSHealthRWES@slideshare.net(IMSHealthRWES) EMR as a highly powerful European RWD source IMSHealthRWES A novel approach for supporting a clinical trial in Europe using EMR data <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/emrasahighlypowerfuleuropeanrwdsource-151222195711-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A novel approach for supporting a clinical trial in Europe using EMR data
EMR as a highly powerful European RWD source from IMSHealthRWES
]]> 30089 9 https://cdn.slidesharecdn.com/ss_thumbnails/emrasahighlypowerfuleuropeanrwdsource-151222195711-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 RWE: A new way to engage IDNs /slideshow/rwe-a-new-way-to-engage-idns/56068035 anewwaytoengageidns-151211213510
As pharmaceutical manufacturers look for ways to build stronger relationships with their Integrated Delivery Network (IDN) clients, RWE is emerging as a desired infrastructure capability, presenting a window of opportunity to support and collaborate on IDN efforts. If done well, these RWE-related partnerships should provide value for both parties involved but require pharma to expand its mindset beyond product-specific approaches.]]>
As pharmaceutical manufacturers look for ways to build stronger relationships with their Integrated Delivery Network (IDN) clients, RWE is emerging as a desired infrastructure capability, presenting a window of opportunity to support and collaborate on IDN efforts. If done well, these RWE-related partnerships should provide value for both parties involved but require pharma to expand its mindset beyond product-specific approaches.]]> Fri, 11 Dec 2015 21:35:09 GMT /slideshow/rwe-a-new-way-to-engage-idns/56068035 IMSHealthRWES@slideshare.net(IMSHealthRWES) RWE: A new way to engage IDNs IMSHealthRWES As pharmaceutical manufacturers look for ways to build stronger relationships with their Integrated Delivery Network (IDN) clients, RWE is emerging as a desired infrastructure capability, presenting a window of opportunity to support and collaborate on IDN efforts. If done well, these RWE-related partnerships should provide value for both parties involved but require pharma to expand its mindset beyond product-specific approaches. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/anewwaytoengageidns-151211213510-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> As pharmaceutical manufacturers look for ways to build stronger relationships with their Integrated Delivery Network (IDN) clients, RWE is emerging as a desired infrastructure capability, presenting a window of opportunity to support and collaborate on IDN efforts. If done well, these RWE-related partnerships should provide value for both parties involved but require pharma to expand its mindset beyond product-specific approaches.
RWE: A new way to engage IDNs from IMSHealthRWES
]]> 2607 8 https://cdn.slidesharecdn.com/ss_thumbnails/anewwaytoengageidns-151211213510-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Building innovative, effective RWE platforms /slideshow/building-innovative-effective-rwe-platforms/55913554 buildinginnovativeeffectiverweplatforms-151208001026-lva1-app6891
As more pharmaceutical companies pursue RWE as a core capability in their organization, they have been increasing their investment in integrated evidence platforms.]]>
As more pharmaceutical companies pursue RWE as a core capability in their organization, they have been increasing their investment in integrated evidence platforms.]]> Tue, 08 Dec 2015 00:10:26 GMT /slideshow/building-innovative-effective-rwe-platforms/55913554 IMSHealthRWES@slideshare.net(IMSHealthRWES) Building innovative, effective RWE platforms IMSHealthRWES As more pharmaceutical companies pursue RWE as a core capability in their organization, they have been increasing their investment in integrated evidence platforms. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/buildinginnovativeeffectiverweplatforms-151208001026-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> As more pharmaceutical companies pursue RWE as a core capability in their organization, they have been increasing their investment in integrated evidence platforms.
Building innovative, effective RWE platforms from IMSHealthRWES
]]> 1244 8 https://cdn.slidesharecdn.com/ss_thumbnails/buildinginnovativeeffectiverweplatforms-151208001026-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Integrate RWE into clinical development /slideshow/integrate-rwe-into-clinical-development/55227530 integraterweintoclinicaldevelopment-151117221620-lva1-app6891
With greater application of RWE throughout the pharmaceutical lifecycle, learnings are emerging that offer guidance for approaches to derive the maximum value. This article captures the author’s experience at a leading international biotech, with insights for smoothing RWE assimilation into clinical development and realizing the benefits it brings.]]>
With greater application of RWE throughout the pharmaceutical lifecycle, learnings are emerging that offer guidance for approaches to derive the maximum value. This article captures the author’s experience at a leading international biotech, with insights for smoothing RWE assimilation into clinical development and realizing the benefits it brings.]]> Tue, 17 Nov 2015 22:16:20 GMT /slideshow/integrate-rwe-into-clinical-development/55227530 IMSHealthRWES@slideshare.net(IMSHealthRWES) Integrate RWE into clinical development IMSHealthRWES With greater application of RWE throughout the pharmaceutical lifecycle, learnings are emerging that offer guidance for approaches to derive the maximum value. This article captures the author’s experience at a leading international biotech, with insights for smoothing RWE assimilation into clinical development and realizing the benefits it brings. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/integraterweintoclinicaldevelopment-151117221620-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> With greater application of RWE throughout the pharmaceutical lifecycle, learnings are emerging that offer guidance for approaches to derive the maximum value. This article captures the author’s experience at a leading international biotech, with insights for smoothing RWE assimilation into clinical development and realizing the benefits it brings.
Integrate RWE into clinical development from IMSHealthRWES
]]> 730 5 https://cdn.slidesharecdn.com/ss_thumbnails/integraterweintoclinicaldevelopment-151117221620-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HEOR, Pharmacoepidemiology & Drug Safety /slideshow/heor-pharmacoepidemiology-drug-safety/54779397 heorpharmacoepidemiologydrugsafety-151105133828-lva1-app6892
IMS Health Real-World Evidence Brochure. Contact us at RWEinfo@imshealth.com to receive the complete brochure.]]>
IMS Health Real-World Evidence Brochure. Contact us at RWEinfo@imshealth.com to receive the complete brochure.]]> Thu, 05 Nov 2015 13:38:28 GMT /slideshow/heor-pharmacoepidemiology-drug-safety/54779397 IMSHealthRWES@slideshare.net(IMSHealthRWES) HEOR, Pharmacoepidemiology & Drug Safety IMSHealthRWES IMS Health Real-World Evidence Brochure. Contact us at RWEinfo@imshealth.com to receive the complete brochure. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/heorpharmacoepidemiologydrugsafety-151105133828-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> IMS Health Real-World Evidence Brochure. Contact us at RWEinfo@imshealth.com to receive the complete brochure.
HEOR, Pharmacoepidemiology & Drug Safety from IMSHealthRWES
]]> 381 4 https://cdn.slidesharecdn.com/ss_thumbnails/heorpharmacoepidemiologydrugsafety-151105133828-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 IMS Health Real-World Evidence Solutions at ISPOR November 2015 /slideshow/ims-health-realworld-solutions-at-ispor-november-2015/54709647 imsrweispormilaninvite-151103220745-lva1-app6891
Welcome to the IMS Health Real-World Evidence (RWE) Solutions program of activities at the forthcoming ISPOR 18th Annual European Congress in Milan. We invite you to join us at more than 70 presentations that spotlight exciting innovations and applications of outcomes research and RWE. And please visit us at our booth to learn more about our pioneering efforts including the e360TM technology suite, RWD Catalogue with 1,800+ data sources identified, and the newly launched RWE Dictionary. Full details of our ISPOR schedule can be found in the brochure. ]]>
Welcome to the IMS Health Real-World Evidence (RWE) Solutions program of activities at the forthcoming ISPOR 18th Annual European Congress in Milan. We invite you to join us at more than 70 presentations that spotlight exciting innovations and applications of outcomes research and RWE. And please visit us at our booth to learn more about our pioneering efforts including the e360TM technology suite, RWD Catalogue with 1,800+ data sources identified, and the newly launched RWE Dictionary. Full details of our ISPOR schedule can be found in the brochure. ]]> Tue, 03 Nov 2015 22:07:45 GMT /slideshow/ims-health-realworld-solutions-at-ispor-november-2015/54709647 IMSHealthRWES@slideshare.net(IMSHealthRWES) IMS Health Real-World Evidence Solutions at ISPOR November 2015 IMSHealthRWES Welcome to the IMS Health Real-World Evidence (RWE) Solutions program of activities at the forthcoming ISPOR 18th Annual European Congress in Milan. We invite you to join us at more than 70 presentations that spotlight exciting innovations and applications of outcomes research and RWE. And please visit us at our booth to learn more about our pioneering efforts including the e360TM technology suite, RWD Catalogue with 1,800+ data sources identified, and the newly launched RWE Dictionary. Full details of our ISPOR schedule can be found in the brochure. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/imsrweispormilaninvite-151103220745-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Welcome to the IMS Health Real-World Evidence (RWE) Solutions program of activities at the forthcoming ISPOR 18th Annual European Congress in Milan. We invite you to join us at more than 70 presentations that spotlight exciting innovations and applications of outcomes research and RWE. And please visit us at our booth to learn more about our pioneering efforts including the e360TM technology suite, RWD Catalogue with 1,800+ data sources identified, and the newly launched RWE Dictionary. Full details of our ISPOR schedule can be found in the brochure.
IMS Health Real-World Evidence Solutions at ISPOR November 2015 from IMSHealthRWES
]]> 2099 10 https://cdn.slidesharecdn.com/ss_thumbnails/imsrweispormilaninvite-151103220745-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-IMSHealthRWES-48x48.jpg?cb=1523538088 https://cdn.slidesharecdn.com/ss_thumbnails/patientadvocacyfromimsrwesaccesspoint12-160607033557-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/advocacy-and-the-cancer-patient-viewpoint/62794080 Advocacy and the cance... https://cdn.slidesharecdn.com/ss_thumbnails/melanomascandifromimsrwesaccesspoint12-160603152035-thumbnail.jpg?width=320&height=320&fit=bounds IMSHealthRWES/accesspoint-excerpt-the-potential-for-rwe-to-improve-care-inmalignant-melanoma AccessPoint Excerpt - ... https://cdn.slidesharecdn.com/ss_thumbnails/patientsubpopulationsfromimsrwesaccesspoint12-160526025935-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/how-patient-subpopulations-are-changing-the-commercialization-of-oncology-products/62410358 How patient subpopulat...